AFP and hepatocellular carcinoma: The COMET‐LR outperformed multiple protein markers (AFP, AFP‐L3, and PIVKA‐II) and published scores for HCC screening (GALAD, Doylestown, and ASAP), in terms of both sensitivity and specificity.